CD8A and neoplasm: Tumour‐derived lactate activates sterol regulatory element‐binding protein 2 (SREBP2) in DCs, promoting mevalonate‐dependent mregDC differentiation that suppresses CD8+ T cells and enhances Th2/Treg responses.64